Scinovex
article Open Access

Review of the possible mechanisms in the prevention of colorectal cancer by probiotic bacterial species

Rajiv Gandhi RBhuvaneswari MeganathanRavi Sankar

Abstract

Several investigations, mainly using in vitro and animal models, have demonstrated a wide range of possible mechanisms, by which probiotics may play a role in colorectal cancer (CRC) prevention. In this context, the most well-studied probiotics are certain strains from the genera of Lactobacillus and bifidobacteria. In recent years, the consumption of over-the-counter probiotics to promote health has grown rapidly worldwide and become an independent industry. In medicine, various studies have demonstrated that probiotics can help improve the immune system and intestinal health. The gut microbiome can play an important role in maintaining homeostasis in the human body. An imbalance in the gut microbiome can lead to pro-inflammatory immune responses and the initiation of disease processes, including cancer. The research results prove some strains of probiotics by modulating intestinal microbiota and immune response can be used for cancer prevention or/and as adjuvant treatment during anticancer chemotherapy. An inverse relationship between the consumption of fermented dairy products, containing Lactobacillus or bifidobacteria (are the main probiotic groups) Pediococcus, Lactococcus, Bacillus, Shirota, Caseii, Lactis, Rhamnosus, Plantarum and yeasts and the incidence of colon, gastric cancer and breast cancer has also been reported in epidemiological and population-based case-control studies. A wealth of data implies that special receptors have essential roles in tumour development. A wealth of evidence emerging from laboratory studies indicates the anticancer activity of probiotics. This review presents the latest advances in research into the effectiveness of probiotics in the prevention and treatment support of cancer. The described issues concern the anticancer activity of probiotic microorganisms and their metabolites. In addition, we described the potential mechanisms of probiotic chemoprevention and the advisability of using probiotics.

Gut microbiota and healthMicrobial Metabolites in Food BiotechnologyFood Industry and Aquatic BiologyProbioticColorectal cancerCancer preventionMedicineCancerBiologyInternal medicineBacteriaGenetics
Citations
0
FWCI
0.00
field-weighted impact
References
75
Percentile
27%
vs. same field & year
References
The gut microbiota shapes intestinal immune responses during health and disease
Nature reviews. Immunology · 2009 · 4,944 citations
Probiotic Bacteria: Selective Enumeration and Survival in Dairy Foods
Journal of Dairy Science · 2000 · 999 citations
Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2010 · 652 citations
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2006 · 483 citations
Functional food science and gastrointestinal physiology and function
British Journal Of Nutrition · 1998 · 1,411 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.